Content
@
0 reply
0 recast
0 reaction
christin
@christin
I've helped dozens of pharmaceutical companies educate healthcare providers about diseases, the latest treatment options, and the harrowing journey patients go through. You would think these are topics that medical schools cover, but healthcare is evolving so quickly that continual medical education is often provided by drug companies. Education is especially vital for rare diseases. They are not top-of-mind for healthcare professionals because they're by definition uncommon. I remember working on marketing a drug for idiopathic pulmonary fibrosis, a rare lung disease. Since treatments available only slowed down progression and are not curative, doctors often opted to "watch and wait." This robbed patients of years of their lives in a silent way. Both my company and the competitor spent millions on medical education, bc the true competitor wasn't between the companies, it was against the inertia of "watch and wait." Yet inertia can be conquered: by educating customers, we empowered them to take action.
18 replies
8 recasts
41 reactions
Angelika Kollin
@angelikakollin
I didn’t know this about you. Impressive.
1 reply
0 recast
0 reaction
christin
@christin
thank you! 🙏 finding opportunities to share a bit more about my "day job" and stories therein.
1 reply
0 recast
0 reaction
Angelika Kollin
@angelikakollin
Fascinating. I know nothing about this field in order to ask questions, only topic I constantly and obsessively explore is on new treatments on depression.
1 reply
0 recast
0 reaction
christin
@christin
ah, let me know if I can assist in that regard! 🫡
1 reply
0 recast
0 reaction
Angelika Kollin
@angelikakollin
As you know, it’s a growing problem worldwide in itself and there is no working and permanent treatment yet.
0 reply
0 recast
0 reaction
